Brain zaps for Parkinson's: tiny trial tests implanted electrodes

NCT ID NCT06919822

Recruiting now Disease control Sponsor: Changping Laboratory Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early trial tests whether a surgically implanted device that stimulates a specific brain network (called SCAN) can improve movement problems in people with Parkinson's disease. Three adults with Parkinson's will receive the implant and be followed for 12 months. The study is very small and open-label, so it is mainly checking safety and whether the approach is worth studying further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: epidural brain stimulation device
What this could lead to: If it works, this could point toward a new way to improve motor symptoms in Parkinson's disease without medication.
What could go wrong: This is a very early, tiny trial with only 3 people. It is open-label (no placebo), so results may not be reliable. Surgery and brain stimulation carry risks like infection or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

The First Affiliated Hospital of Fujian Medical University
RECRUITING

Fuzhou, Fujian, 350005, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.